TPH1 and colitis: The inhibition of serotonin production using a specific inhibitor of TPH1 decreases the severity of trinitrobenzene sulfonic acid-induced colitis in mice, indicating that the enzymatic regulation of HT-5 synthesis may influence on the development of improved therapeutic strategies in inflammatory disorders [35].